Sign in

CIK 0001731348 · Large accelerated filer

Tilray Brands, Inc.

Sign in to watch
Ticker
TLRY
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
May 31
Entity type
operating
EIN
824310622
Phone
519.322.8800
Business address
445 PARK AVENUE, NEW YORK, NY, 10022
Former names
Tilray, Inc.
  1. 4 Option exercise President and CEO acquired 706,216 shares (option exercise)
  2. 4 Option exercise Chief Financial Officer acquired 93,928 shares (option exercise)
  3. 4 Open-market buy Global General Counsel bought 6,000 shares at $0.58 ($3,496)
  4. 4 Option exercise Chief Strategy Officer acquired 93,928 shares (option exercise)
  5. 4 Option exercise Chief Strategy Officer acquired 261,194 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise Director acquired 124,378 shares (option exercise)
  8. 4 Option exercise Director acquired 124,378 shares (option exercise)
  9. 4 Option exercise Director acquired 124,378 shares (option exercise)
  10. 4 Option exercise Director acquired 124,378 shares (option exercise)
  11. 4 Option exercise Director acquired 124,378 shares (option exercise)
  12. 4 Option exercise Global General Counsel acquired 243,781 shares (option exercise)
  13. 4 Option exercise Chief Financial Officer acquired 166,558 shares (option exercise)
  14. 4 Option exercise President and CEO acquired 1,176,467 shares (option exercise)
  15. 4 Open-market buy President and CEO bought 165,000 shares at $0.61 ($100,106)
  16. 4 Open-market buy Chief Financial Officer bought 33,500 shares at $0.60 ($19,939)
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 8-K Event Unregistered share sale
  20. 8-K Event Shareholder vote results

Page 4 of 39 · 770 filings